Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2011

Jun 7, 2011

34975_dirs_2011-06-07_b4fdf38c-52f7-4b0b-9854-43737390576e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2011-06-02

Reporting Person: GREEN DAVID (Director, President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-02 Common Stock A 53750 Acquired 1517152 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-06-02 Stock Option (right to buy) $5.64 A 107500 Acquired 2021-06-02 Common Stock, par value $0.01 per share (107500) Direct

Footnotes

F1: Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; (b) a deferred stock award of 53,750 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013; January 1, 2014; and January 1, 2015; and (c) 1,363,202 shares of common stock held by Mr. Green

F2: The options vest in four equal installments on the first four anniversaries of January 1, 2011